Guggenheim Capital’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$124K Sell
11,025
-236
-2% -$2.66K ﹤0.01% 1546
2025
Q1
$107K Sell
11,261
-106
-0.9% -$1K ﹤0.01% 1596
2024
Q4
$128K Sell
11,367
-803
-7% -$9.03K ﹤0.01% 1641
2024
Q3
$344K Buy
12,170
+64
+0.5% +$1.81K ﹤0.01% 1555
2024
Q2
$231K Sell
12,106
-320,323
-96% -$6.12M ﹤0.01% 1724
2024
Q1
$10.9M Buy
332,429
+7,457
+2% +$245K 0.08% 293
2023
Q4
$10.7M Hold
324,972
0.08% 290
2023
Q3
$8.85M Hold
324,972
0.08% 313
2023
Q2
$9.85M Sell
324,972
-52,260
-14% -$1.58M 0.08% 299
2023
Q1
$12.2M Hold
377,232
0.1% 227
2022
Q4
$10.6M Hold
377,232
0.09% 269
2022
Q3
$13.6M Sell
377,232
-1
-0% -$36 0.12% 193
2022
Q2
$11.6M Sell
377,233
-103,143
-21% -$3.17M 0.09% 260
2022
Q1
$15.5M Sell
480,376
-18,615
-4% -$601K 0.09% 247
2021
Q4
$13.8M Buy
498,991
+1,096
+0.2% +$30.3K 0.07% 308
2021
Q3
$15.4M Sell
497,895
-18,388
-4% -$570K 0.09% 239
2021
Q2
$10.9M Sell
516,283
-148,082
-22% -$3.13M 0.06% 370
2021
Q1
$13.4M Hold
664,365
0.09% 270
2020
Q4
$10.7M Buy
664,365
+193,736
+41% +$3.11M 0.07% 316
2020
Q3
$5.84M Hold
470,629
0.04% 465
2020
Q2
$3.35M Hold
470,629
0.03% 674
2020
Q1
$2.56M Buy
470,629
+250
+0.1% +$1.36K 0.03% 681
2019
Q4
$4.26M Buy
470,379
+3,903
+0.8% +$35.3K 0.03% 697
2019
Q3
$3.35M Buy
466,476
+184,294
+65% +$1.33M 0.03% 792
2019
Q2
$2.24M Buy
282,182
+75
+0% +$596 0.02% 1012
2019
Q1
$3.55M Sell
282,107
-34,211
-11% -$430K 0.03% 790
2018
Q4
$6.31M Buy
316,318
+144,263
+84% +$2.88M 0.05% 438
2018
Q3
$4.89M Buy
+172,055
New +$4.89M 0.03% 734